# Anti-Reflux Mucosal Ablation(ARMA) and Anti-Reflux Mucosectomy(ARMS) in Gastroesophageal Reflux Disease

> **NCT05422404** · NA · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 150 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease
- Endoscopy

## Interventions

- **PROCEDURE:** Anti-Reflux Mucosectomy
- **PROCEDURE:** Anti-reflux mucosal ablation

## Key facts

- **NCT ID:** NCT05422404
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-30
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05422404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05422404, "Anti-Reflux Mucosal Ablation(ARMA) and Anti-Reflux Mucosectomy(ARMS) in Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05422404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*